Howard Capital Management Group’s iShares Biotechnology ETF IBB Stock Holding History

Howard Capital Management Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.49M	Sell	28,887 -296	-1%	-$50.9K	0.34%	33
2026 Q1	$4.93M	Sell	29,183 -3,369	-10%	-$576K	0.33%	35
2025 Q4	$5.49M	Sell	32,552 -960	-3%	-$156K	0.35%	34
2025 Q3	$4.84M	Sell	33,512 -5,315	-14%	-$725K	0.31%	36
2025 Q2	$4.91M	Sell	38,827 -840	-2%	-$103K	0.34%	35
2025 Q1	$5.07M	Sell	39,667 -3,845	-9%	-$521K	0.4%	33
2024 Q4	$5.75M	Sell	43,512 -80	-0.2%	-$11.2K	0.39%	35
2024 Q3	$6.35M	Sell	43,592 -175	-0.4%	-$25.3K	0.45%	34
2024 Q2	$6.01M	Sell	43,767 -415	-0.9%	-$55.4K	0.44%	35
2024 Q1	$6.06M	Sell	44,182 -269	-0.6%	-$36.7K	0.47%	35
2023 Q4	$6.04M	Sell	44,451 -570	-1%	-$69.5K	0.52%	34
2023 Q3	$5.51M	Sell	45,021 -129	-0.3%	-$16.4K	0.53%	34
2023 Q2	$5.73M	Sell	45,150 -356	-0.8%	-$46.2K	0.53%	34
2023 Q1	$5.88M	Hold	45,506	–	–	0.62%	32
2022 Q4	$5.97M	Sell	45,506 -335	-0.7%	-$43.3K	0.72%	32
2022 Q3	$5.36M	Sell	45,841 -244	-0.5%	-$30.3K	0.68%	32
2022 Q2	$5.42M	Sell	46,085 -175	-0.4%	-$20.8K	0.64%	34
2022 Q1	$6.03M	Sell	46,260 -165	-0.4%	-$21.5K	0.55%	36
2021 Q4	$7.08M	Sell	46,425 -150	-0.3%	-$23.2K	0.58%	36
2021 Q3	$7.53M	Sell	46,575 -146	-0.3%	-$24.6K	0.7%	35
2021 Q2	$7.65M	Sell	46,721 -950	-2%	-$146K	0.72%	35
2021 Q1	$7.18M	Buy	+47,671	New	+$7.57M	0.75%	35

Other funds holding IBB

GIC

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

FNFDCM

Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

RFA

Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

NRS

Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return

MCG

McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

SCA

Southern Capital Advisors Jackson, Tennessee $239M AUM 22.42% 1-Year Est. Return

Howard Capital Management Group's IBB Position: Q2 2026 in Review

Howard Capital Management Group reduced its iShares Biotechnology ETF (IBB) stake by 1% in Q2 2026, selling an estimated $50.9K and leaving 28,887 shares worth $5.49M. The position accounts for 0.34% of the portfolio, ranked #33.

Howard Capital Management Group first reported a position in IBB in Q1 2021 and has held it in 22 quarters since. The position peaked at $7.65M in Q2 2021. 158 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Howard Capital Management Group held 28,887 shares of iShares Biotechnology ETF worth $5.49M as of Q2 2026.
Howard Capital Management Group sold 296 iShares Biotechnology ETF shares in Q2 2026, an estimated $50.9K.
iShares Biotechnology ETF made up 0.34% of Howard Capital Management Group's portfolio in Q2 2026, its #33 holding.
Howard Capital Management Group first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 22 quarters since.
Howard Capital Management Group's iShares Biotechnology ETF position peaked at $7.65M in Q2 2021.
158 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Howard Capital Management Group's 13F filing for Q2 2026, filed 16 Jul 2026.